Osaka, Japan

Hiroko Nishimura

This inventor holds 1 USPTO granted patent. Top assignee: The Green Cross Corporation. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroko Nishimura. Retrieved from https://idiyas.com/inventor/hiroko-nishimura-2qep2q0u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroko Nishimura: Innovator in Pharmaceutical Chemistry

Introduction

Hiroko Nishimura is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development efforts. Her work has led to the creation of valuable patents that enhance medical treatments.

Latest Patents

Hiroko holds a patent for a triazole derivative and its pharmaceutical use. This invention showcases her expertise in developing compounds that can potentially improve therapeutic outcomes in various medical applications. She has 1 patent to her name, reflecting her dedication to advancing pharmaceutical science.

Career Highlights

Hiroko is currently employed at The Green Cross Corporation, a company known for its commitment to healthcare and innovative solutions. Her role at the company allows her to collaborate with other talented professionals in the field, furthering her impact on pharmaceutical advancements.

Collaborations

Throughout her career, Hiroko has worked alongside notable colleagues, including Fumihiko Akahoshi and Takehiro Okada. These collaborations have enriched her research and contributed to the success of her projects.

Conclusion

Hiroko Nishimura is a trailblazer in pharmaceutical chemistry, with a focus on innovative compounds that can enhance medical treatments. Her contributions to the field are noteworthy, and her ongoing work continues to inspire future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…